Advertisement


Trials
India  /  Published 03.09.21

Cobrevax: Nod for trial on kids

Biological E has received approval for conducting phase II/III human clinical trial of Covid-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology...
By Our Bureau, PTI in New Delhi

India  /  Published 06.06.21

Covid-19: Trial for Niclomiside begins

The CSIR and Laxai Life Sciences Private Limited have initiated phase II clinical trials of anti-helminitic drug Niclosamide' for the treatment of Covid-19 patients, a statement said on Sunday. T...
By Our Bureau, Agencies in New Delhi

Calcutta  /  Published 07.01.21

Vaccine dry run tomorrow

The second dry run for Covid vaccination will be held on Friday across 23 districts of Bengal. Each district will have three vaccination centres. The first dry run was restricted to three centres in ...
By Kinsuk Basu in Calcutta

India  /  Published 16.12.20

Integrated effort to support and promote vaccine

The Indian government is making all efforts to support and promote the development of Covid-19 vaccine, however, there is a need to strengthen cold chain logistics and remove vaccine hesitancy, expert...
By Our Bureau and Agencies in New Delhi

India  /  Published 11.12.20

Trial nod for homegrown RNA-based vaccine

Two years ago, Sanjay Singh, a biochemist and chief executive officer of a Pune-based biotechnology company producing drugs for cancers and strokes, turned his attention to a new “platform&rdquo...
By G.S. Mudur in New Delhi

Advertisement

World  /  Published 21.10.20

Covid: human challenge trial in UK

Researchers at Imperial College London are planning to deliberately infect healthy volunteers with the coronavirus early next year as part of the world’s first effort to study how people immunis...
By New York Times News Service in London

India  /  Published 03.08.20

Vaccine: 10-city trial plan

India’s department of biotechnology has selected 10 cities where several thousand healthy volunteers could join the anticipated large-scale clinical trials to assess the efficacy of candidate va...
By G.S. Mudur in New Delhi

Opinion  /  Published 28.07.20

The fact of the matter

We read a recent opinion article titled, “An opaque model of drug approval”, in The Telegraph with interest. We respectfully disagree with the author, and appreciate the opportun...
By Sundar Ramanan

India  /  Published 24.07.20

Covaxin human trial: Man given first dose at AIIMS Delhi

The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS in New Delhi on Friday with the first dose of the injection ...
By PTI in New Delhi

India  /  Published 22.07.20

Oxford vaccine to be tested on 1,500 Indians

The candidate vaccine against the new coronavirus disease developed by Oxford researchers and shown as safe and able to induce promising immune responses will be tested in India, among other countries...
By G.S. Mudur in New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.